Masimo Co. (NASDAQ:MASI) EVP Yongsam Lee sold 10,000 shares of the business’s stock in a transaction on Friday, January 5th. The stock was sold at an average price of $88.17, for a total transaction of $881,700.00. Following the completion of the transaction, the executive vice president now owns 75,018 shares in the company, valued at approximately $6,614,337.06. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Yongsam Lee also recently made the following trade(s):

  • On Friday, December 1st, Yongsam Lee sold 5,900 shares of Masimo stock. The stock was sold at an average price of $88.31, for a total transaction of $521,029.00.
  • On Monday, December 4th, Yongsam Lee sold 18,198 shares of Masimo stock. The stock was sold at an average price of $88.85, for a total transaction of $1,616,892.30.
  • On Thursday, November 9th, Yongsam Lee sold 13,976 shares of Masimo stock. The stock was sold at an average price of $89.43, for a total transaction of $1,249,873.68.
  • On Wednesday, November 1st, Yongsam Lee sold 5,000 shares of Masimo stock. The stock was sold at an average price of $89.89, for a total transaction of $449,450.00.

Shares of Masimo Co. (MASI) opened at $88.47 on Wednesday. The firm has a market cap of $4,570.00, a PE ratio of 14.02, a PEG ratio of 3.41 and a beta of 0.72. Masimo Co. has a 1 year low of $68.87 and a 1 year high of $104.71.

Masimo (NASDAQ:MASI) last released its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.53 by $0.17. The company had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. Masimo had a net margin of 45.83% and a return on equity of 22.17%. The company’s revenue was up 15.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.52 EPS. sell-side analysts anticipate that Masimo Co. will post 2.95 earnings per share for the current year.

MASI has been the topic of a number of recent analyst reports. Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price objective on shares of Masimo in a report on Friday, November 3rd. Zacks Investment Research upgraded shares of Masimo from a “hold” rating to a “buy” rating and set a $98.00 price objective on the stock in a report on Thursday, November 2nd. Finally, BidaskClub lowered shares of Masimo from a “hold” rating to a “sell” rating in a report on Thursday, December 7th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $97.17.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. State Street Corp increased its position in shares of Masimo by 10.4% in the 2nd quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock worth $141,121,000 after purchasing an additional 146,212 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of Masimo by 76.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock worth $73,191,000 after purchasing an additional 347,360 shares during the last quarter. BlackRock Inc. increased its position in shares of Masimo by 7.5% in the 2nd quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock worth $721,710,000 after purchasing an additional 550,995 shares during the last quarter. Koch Industries Inc. increased its position in shares of Masimo by 5,053.7% in the 2nd quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock worth $439,000 after purchasing an additional 435,325 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its position in shares of Masimo by 3.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,113,113 shares of the medical equipment provider’s stock worth $101,494,000 after purchasing an additional 38,991 shares during the last quarter. 83.69% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: “Yongsam Lee Sells 10,000 Shares of Masimo Co. (MASI) Stock” was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another publication, it was copied illegally and republished in violation of international copyright and trademark laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2018/01/10/yongsam-lee-sells-10000-shares-of-masimo-co-masi-stock.html.

About Masimo

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.